Cancer Stem Cells
The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.
Brain Stem Neoplasms are cancers that are common in children and can occur in the mesencephalon, pons or medulla oblongata. Discover the latest research on Brain Stem Neoplasms here.
Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.
DPP4 has the potential to truncate proteins. DPP4-mediated truncation of certain chemokines, interleukins, and colony stimulating factors have recently been linked to regulation of hematopoietic stem/progenitor cells. Given its role in tumor biology, it is also used as a marker for various cancers. Here is the latest research.
Liver stem cells are fast to growth and differentiate, which is a key factor in liver regeneration. They could potentially provide a limitless source of cells that are being examined for a variety of clinical applications. Discover the latest research on liver stem cells here.
Hematopoietic stem cells reside in the bone marrow and give rise to lymphoid and myeloid stem cells, which differentiate into various cell types. This feed focuses on factors and mechanisms that underlie differentiation of lymphoid stem cells.
Prostate stem cells are important for the development, maturation and function of the prostate. They can give rise to three types of prostate epithelial cells and have been implicated in both benign prostate hyperplasia and prostate cancer. Here is the latest research on prostate stem cells.
The cancer stem cell theory proposes that, in tumors, there exist a sub-population of cells that possess characteristics of normal stem cells, specifically the ability to self-renew, and that these cells proliferate and sustain the cancer. Here is the latest research on stem and cancer cells.
Cell therapies derived from induced Pluripotent Stem Cell (iPSC) technology is emerging in cancer therapeutics. For example, iPSCs allow the development of immune therapies and drug screening programs in the genetic background of the patient. Discover the latest research on iPSC derived cell therapies for cancer here.
Long non-coding RNAs (lncRNA) are a class of RNAs that exceed 200 nucleotides in length and cannot be translated into proteins. LncRNAs have been shown to regulate several cellular processes and signaling pathways. Here is the latest research on their role in stem cells and cancer.